Skip to content
ABOUT
AUTHOR GUIDELINES
AUTHORS/EDITORS
SUBSCRIPTIONS
CONTACT US
MY ACCOUNT
Facebook
X
LinkedIn
Instagram
Search
×
HOME
JOURNALS
PSYCHOPHARMACOLOGY BULLETIN
FULL ISSUE STACKED PDFs
T.E.N.
MENTAL FITNESS
PSI
ONCOLOGY SPECTRUMS
PROJECTS
JOURNAL SUPPLEMENTS
PHYSICIAN ACADEMY SERIES
POCKET REFERENCE GUIDES
TEACHING MONOGRAPHS
MEDWORKS REPRINT SERIES
RESOURCES
PSYCHOTROPICS A-Z
PSYCHOPHARMACOLOGY 101
PSYCHIATRIC RATING SCALES
NEWS
Risperidone: Review of Its Therapeutic Utility in Depression
1 x
$
30.00
View Cart
Checkout
Home
The Next Step Forward: A Move Toward Evidence, and Away From Fear of the Industry
“Risperidone: Review of Its Therapeutic Utility in Depression” has been added to your cart.
View cart
The Next Step Forward: A Move Toward Evidence, and Away From Fear of the Industry
$
0.00
The Next Step Forward: A Move Toward Evidence, and Away From Fear of the Industry quantity
Add to cart
Want a discount? Become a member by purchasing
Psychopharmacology Bulletin Subscription - Individual
!
Categories:
Psychopharmacology Bulletin
,
VOL 36 No. 4 Articles
Tags:
a-move-toward-evidence
,
editors-note
,
industry
,
michael-e-thase
Description
Description
Editor’s Note: The Next Step Forward: A Move Toward Evidence, and Away From Fear of the Industry – Michael E. Thase, MD
Related products
Robert MA Hirschfeld, MD: Defining the Clinical Course of Bipolar Disorder: Response, Remission, Relapse, Recurrence, and Roughening
$
30.00
Add to cart
Details
Optimizing Treatment Outcomes for Patients With Depression and Generalized Anxiety Disorder
$
30.00
Add to cart
Details
Psychopharmacology Bulletin VOL 36 Supplement No. 3 – Full Issue Stacked PDF
$
60.00
Add to cart
Details
Revisiting the Effectiveness of Standard Antidepressants in Bipolar Disorder: Are Monoamine Oxidase Inhibitors Superior?
$
30.00
Add to cart
Details
Page load link
Go to Top
